Adderall Buyers Slam Drugmaker's Class Cert. Objections
Consumers accusing Shire US Inc. of paying off generic rivals to delay selling cheaper versions of Adderall defended their bid for class certification in the antitrust suit Friday, arguing that under...To view the full article, register now.
Already a subscriber? Click here to view full article